Percutaneous Plug-based Arteriotomy Closure Device Use in Minimally Invasive Cardiac Surgery

Last updated: July 14, 2022
Sponsor: Karolinska University Hospital
Overall Status: Active - Recruiting

Phase

N/A

Condition

Open Heart Surgery

Treatment

N/A

Clinical Study ID

NCT05462769
MANTA continued
  • Ages > 18
  • All Genders

Study Summary

A single-center prospective study. Patients undergoing minimally invasive cardiac surgery between 2017 and 2022 at the Karolinska University Hospital in Stockholm, Sweden are eligible. Femoral cannulation was performed percutaneously with planned percutaneous arteriotomy closed using a plug-based arteriotomy closure device (MANTA; Teleflex/Essential Medical, Malvern, PA). Data regarding preoperative clinical characteristics and operative details were obtained by medical records review.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Operated with minimally invasive cardiac surgery between 2017 and 2022 at theKarolinska University Hospital in Stockholm, Sweden, with use of percutaneous femoralcannulation with planned percutaneous arteriotomy closed using a plug-basedarteriotomy closure device.

Exclusion

Exclusion Criteria:

  • None.

Study Design

Total Participants: 600
Study Start date:
August 01, 2017
Estimated Completion Date:
December 31, 2022

Connect with a study center

  • Karolinska University Hospital

    Stockholm,
    Sweden

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.